Hemophilia A Without Inhibitors: Personalizing Therapy With Factor VIII Prophylaxis

Review multidisciplinary perspectives on leveraging clotting factor concentrates for prophylaxis of hemophilia A with downloadable slidesets from the Webcast at THSNA 2020.
Michael Callaghan, MD
Miguel A. Escobar, MD
Guy A. Young, MD

Downloadable Slidesets

Downloadable slides with expert analysis on the use of EHL Factor VIII therapy for patients with hemophilia A.

Guy A. Young, MD Released: October 29, 2020

Downloadable slides with expert analysis on the importance of PK monitoring with EHL Factor VIII therapy for patients with hemophilia A.

Michael Callaghan, MD Released: October 29, 2020

Downloadable slides with expert analysis on the management of cardiovascular and other comorbidities in older patients with hemophilia A.

Miguel A. Escobar, MD Released: October 29, 2020

Download this summary slideset with essential expert insights on the clinical management of patients with hemophilia A.

Michael Callaghan, MD Miguel A. Escobar, MD Guy A. Young, MD Released: November 5, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Takeda Pharmaceuticals USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue